Why COVID-19 trials should be blinded (as any other one)

Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Carolina de Oliveira Cruz Latorraca, Rachel Riera

Keywords


Blinding. Clinical trials. COVID-19.

Full Text:

PDF


DOI: http://dx.doi.org/10.17267/2675-021Xevidence.v2i1.2841

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Carolina de Oliveira Cruz Latorraca, Rachel Riera

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This journal has been indexed and/or catalogued in the following database:

   

      

Journal of Evidence-Based Healthcare | ISSN 2675-021X

Updated 01/03/2020

Creative Commons License